Recombinant Human Interleukin-2 for Injection Market

Interleukin-2 is ia type of medication called a biologic response modifier. It is a type of protein called a cytokine that works to increase the production and function of some parts of your body's immune system.
Recombinant Human Interleukin-2 for Injection Market contains market size and forecasts of Recombinant Human Interleukin-2 for Injection in global, including the following market information:
Global Recombinant Human Interleukin-2 for Injection Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Recombinant Human Interleukin-2 for Injection Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Recombinant Human Interleukin-2 for Injection companies in 2022 (%)
The global Recombinant Human Interleukin-2 for Injection market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
50000 IU Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Recombinant Human Interleukin-2 for Injection include Clinigen, 3SBio, Beijing Four Rings Biopharmaceutical, Jiangsu Kingsley Pharmaceutical, Beijing Yuance Pharmaceutical, Beijing SL Pharm, Shanghai Huaxin Biotechnology, Changchun Institute Of Biological Products and Shandong Quangang Pharmaceutical. etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Human Interleukin-2 for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Interleukin-2 for Injection Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Recombinant Human Interleukin-2 for Injection Market Segment Percentages, by Type, 2022 (%)
50000 IU
100000 IU
200000 IU
500000 IU
1 Million IU
Global Recombinant Human Interleukin-2 for Injection Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Recombinant Human Interleukin-2 for Injection Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Recombinant Human Interleukin-2 for Injection Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Recombinant Human Interleukin-2 for Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Interleukin-2 for Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Human Interleukin-2 for Injection revenues share in global market, 2022 (%)
Key companies Recombinant Human Interleukin-2 for Injection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Recombinant Human Interleukin-2 for Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Clinigen
3SBio
Beijing Four Rings Biopharmaceutical
Jiangsu Kingsley Pharmaceutical
Beijing Yuance Pharmaceutical
Beijing SL Pharm
Shanghai Huaxin Biotechnology
Changchun Institute Of Biological Products
Shandong Quangang Pharmaceutical